NeoChord Announces a Research Collaboration with the Skirball Center for Innovation at the Cardiovascular Research Foundation

January 2018


Andrew ElBardissi, M.D. Named to NeoChord Board of Directors

June 2017


First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation;

November 9, 2016

click for release

NeoChord passes 500 patient treatment milestone follow-up data on 127 patients out to two years presented at EACTS;

October 28, 2016

click for release

NeoChord announces appointment of Alex Jonkers as VP of European Commercial Sales and milestone of over 400 patients treated with the DS1000 System;

May 5, 2016

Click for Release

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation;

May 13, 2016

Click for Release